Study guide
20.1 Biophysical Profile & Fetal Surveillance
ARRT Sonography Primary
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 Current Exam Facts & Logistics 1.2 Scoring, Section Minimums & the August 2026 Cut-Score Change 1.3 Official Blueprint & Study Strategy
2 Patient Care: Ethics, Legal Practice & Communication
2.1 Ethical & Legal Aspects of Patient Care 2.2 Interpersonal Communication & Patient Education 2.3 Physical Assistance, Monitoring & Sonographer Ergonomics
3 Patient Care: Safety, Emergencies & Infection Control
3.1 Medical Emergencies & Critical Findings 3.2 Infection Control & Hazardous Materials 3.3 Ultrasound Safety & Interventional Procedure Care
4 Image Production: Transducers & the Ultrasound Beam
4.1 Piezoelectric Effect & Transducer Construction 4.2 Beam Configuration: Near Field, Far Field & Focus 4.3 Transducer Types, Selection, Care & Malfunctions
5 Image Production: Pulse Characteristics & Resolution
5.1 Pulse Characteristics: PRF, PRP, SPL & Duty Factor 5.2 Resolution: Axial, Lateral, Temporal, Elevational & Contrast 5.3 Frequency, Bandwidth, Q Factor, Power, Pressure, Intensity & Amplitude
6 Image Production: Imaging Modes & Doppler Principles
6.1 B-Mode & M-Mode Imaging 6.2 Spectral Doppler: Pulsed Wave vs Continuous Wave 6.3 Color Doppler & Power Doppler
7 Image Production: Optimization Controls
7.1 Power, Gain, TGC, Depth & Focal Zone 7.2 Frame Rate, Line Density, Dynamic Range, Harmonics & Compounding 7.3 Doppler Optimization Controls
8 Image Production: Sound–Tissue Interactions
8.1 Speed of Sound & the Range Equation 8.2 Acoustic Impedance, Reflection, Refraction & Scattering 8.3 Attenuation, Absorption & Intensity
9 Image Production: Signal Processing, Display & Bioeffects
9.1 Receiver, Signal Processing & Analog-Digital Conversion 9.2 Postprocessing, Magnification, Panoramic & 3D/4D Imaging 9.3 Bioeffects & Output Display Measures
10 Image Production: Image Evaluation & Artifacts
10.1 Criteria for Diagnostic Quality & Annotation 10.2 Grayscale Artifacts 10.3 Doppler Artifacts
11 Image Production: Real-Time Interpretation & Informatics
11.1 Real-Time Imaging, Echogenicity & Echotexture 11.2 Color & Spectral Analysis: Measurements and Waveforms 11.3 Imaging Informatics: HIS, RIS, EMR, PACS & DICOM
12 Procedures: Abdominal & Transplant Vasculature
12.1 Aorta, Its Branches & the IVC 12.2 Portal Venous System & Hepatic Vasculature 12.3 Liver & Renal Transplant Sonography
13 Procedures: Liver
13.1 Liver Anatomy, Variants & Examination Technique 13.2 Diffuse Liver Disease 13.3 Focal Liver Lesions
14 Procedures: Biliary System, Pancreas & Spleen
14.1 Gallbladder & Bile Ducts 14.2 Pancreas 14.3 Spleen
15 Procedures: Urinary Tract, GI Tract & Other Abdominal Structures
15.1 Kidneys & Ureters 15.2 Bladder & Prostate 15.3 GI Tract, Adrenals, Lymph Nodes, Hernias & Peritoneal Cavity
16 Procedures: First-Trimester Obstetrics
16.1 Early Gestation: Normal Development & Structures 16.2 First-Trimester Measurements, Dating & Maternal Anatomy 16.3 First-Trimester Abnormalities
17 Procedures: Second/Third-Trimester Biometry & Fetal Survey
17.1 Standard Biometry: BPD, HC, AC, FL & Growth Assessment 17.2 Fetal Anatomic Survey: Head, CNS, Face & Spine 17.3 Fetal Anatomic Survey: Heart, Chest, GI, GU, Skeleton & Fetal Position
18 Procedures: Chromosomal, Genetic & Structural Abnormalities
18.1 Chromosomal & Genetic Abnormalities 18.2 Major Structural Anomalies by System 18.3 Fetal Infection, Neoplasms & Hydrops
19 Procedures: Placenta, Amniotic Fluid, Cord & Cervix
19.1 Placenta: Normal, Previa, Abruption & Accreta 19.2 Amniotic Fluid Assessment & Growth Disorders 19.3 Umbilical Cord & Cervical Assessment
20 Procedures: Fetal Assessment, Doppler & Multiple Gestation
20.1 Biophysical Profile & Fetal Surveillance 20.2 Fetal & Uteroplacental Doppler 20.3 Multiple Gestations, Assisted Reproduction & Maternal Disease
21 Procedures: Gynecology — Uterus
21.1 Uterine Anatomy, Myometrium & Fibroids 21.2 Endometrium: Cyclic Changes, Hyperplasia & Cancer 21.3 Cervix & Congenital Uterine Anomalies
22 Procedures: Gynecology — Adnexa & Pelvis
22.1 Ovaries: Normal, Functional Cysts & Benign Masses 22.2 Ovarian Malignancy, Torsion & Fallopian Tubes 22.3 Cul-de-Sac, Vagina & Pelvic Floor
23 Procedures: Neck & Scrotum
23.1 Thyroid & Parathyroid 23.2 Salivary Glands & Neck Lymph Nodes 23.3 Scrotum & Testes
24 Procedures: Breast & Peripheral Vascular
24.1 Breast & Axilla 24.2 Venous Extremity Doppler 24.3 Carotid Doppler & Post-Catheterization Complications
25 Procedures: Pediatric, Interventional & Miscellaneous
25.1 Neonatal Head, Spine & Hip Sonography 25.2 Pediatric GI & Noncardiac Chest 25.3 Ultrasound-Guided Interventions, MSK & Superficial Masses
20.1 Biophysical Profile & Fetal Surveillance
Key Takeaways Explain This Topic AI
A full biophysical profile scores five components 0 or 2 points each: NST, fetal breathing movements, gross body movement, fetal tone, and amniotic fluid volume; 8-10 is reassuring, 6 is equivocal, and 4 or less is abnormal
Acute parameters fail in a fixed order under hypoxia - NST first, then breathing, then movement, then tone last - while amniotic fluid volume is the only marker of chronic hypoxia
Normal criteria within a 30-minute window: at least 3 body movements, one breathing episode of 30 seconds or more, one extension-with-flexion episode, and a deepest fluid pocket of 2 cm or more
The modified BPP pairs the NST with the amniotic fluid index; an AFI of 5 cm or less defines oligohydramnios and triggers a full BPP or further testing
Common indications include diabetes, hypertension, IUGR, decreased fetal movement, and post-term pregnancy, with testing reliable from about 26-28 weeks onward
Last updated: July 2026
The Biophysical Profile (BPP)
The biophysical profile (BPP) is the standard sonographic tool for assessing fetal well-being in the second half of pregnancy. A complete BPP combines the non-stress test (NST) from electronic fetal heart rate monitoring with four parameters observed in real time with ultrasound: fetal breathing movements (FBM) , gross fetal body movement (FM) , fetal tone (FT) , and amniotic fluid volume (AFV) . Each of the five components is scored 2 when normal and 0 when abnormal, producing a score out of 10 (out of 8 when the NST is omitted, as many protocols allow when all four sonographic parameters are normal).
Scoring criteria for each component
Component Normal finding (2 points)
NST (non-stress test) Reactive: at least 2 accelerations of 15 beats/min or more, each lasting 15 seconds or more, within 20 minutes
Fetal breathing movements At least 1 episode of rhythmic breathing lasting 30 seconds or more within 30 minutes
- Gross body movement At least 3 discrete body or limb movements within 30 minutes
- Fetal tone At least 1 episode of extension with return to flexion (for example, the hand opening and closing)
- Amniotic fluid volume A single deepest vertical pocket of 2 cm or more, measured in two perpendicular planes
- Physiologic basis: acute versus chronic hypoxia
The parameters are not interchangeable. Four of them reflect acute central nervous system function and are suppressed by hypoxia in a predictable order that mirrors the oxygen sensitivity of each CNS center: the NST is lost first, then fetal breathing movements, then gross body movement, and finally fetal tone. Recovery runs in the opposite direction: fetal tone — governed by the earliest CNS centre to develop (about 7.5 to 8.5 weeks) and therefore the last parameter lost — is the first to return once the fetus is reoxygenated, while FHR reactivity , governed by the last centre to mature (about 24 to 28 weeks), is the first lost and the last to return. The mnemonic first to go is the last to return applies to reactivity, not to tone. Amniotic fluid volume is the only chronic marker: sustained hypoxemia redistributes fetal cardiac output toward the brain, heart, and adrenal glands and away from the kidneys, so fetal urine output falls and oligohydramnios develops over days. This is why a fetus with normal tone, movement, and breathing but a small fluid pocket is managed differently from a fetus showing the reverse pattern.
The sonographic observation window is 30 minutes, and each parameter must be demonstrated within that window to earn its 2 points. A full BPP is generally considered reliable from about 26 to 28 weeks of gestation onward, once fetal behavioral states have matured enough to be interpreted.
Interpretation and management of the score
10/10 or 8/8 with normal fluid : reassuring; perinatal mortality is very low; repeat testing on the schedule dictated by the indication (weekly or twice weekly).
8/10 : generally reassuring if fluid is normal; an 8/10 caused by oligohydramnios alone is more concerning than one caused by a missing acute parameter and may prompt delivery at term.
6/10 : equivocal. Repeat the BPP within 24 hours; delivery is usually recommended if the pregnancy is at term, if oligohydramnios persists, or if the repeat score remains equivocal.
4/10 or less : abnormal. A score of 4 usually leads to delivery planning once the fetus is viable, and scores of 0 to 2 carry an extremely high perinatal mortality and mandate urgent evaluation, usually with immediate delivery in a viable fetus. The classic Vintzileos data showed perinatal mortality climbing steeply as the score falls below 6.
Indications for surveillance
Common indications include pregestational and gestational diabetes, chronic hypertension and preeclampsia, suspected fetal growth restriction (FGR) - also called intrauterine growth restriction (IUGR) - decreased fetal movement, post-term pregnancy (testing commonly begins at 41 weeks), isoimmunization or other risk of fetal anemia, prior stillbirth, preterm premature rupture of membranes, and multiple gestation with growth discordance. High-risk pregnancies are typically tested weekly or twice weekly.
The modified BPP
The modified biophysical profile pairs the NST with the amniotic fluid index (AFI) , the sum of the deepest vertical fluid pocket in each of the four uterine quadrants. A normal AFI is roughly 5 to 25 cm; an AFI of 5 cm or less defines oligohydramnios, and an AFI above 24 to 25 cm defines polyhydramnios. The modified BPP predicts fetal well-being nearly as well as the full BPP with far less scanning time, so it is the most common first-line surveillance test; an abnormal result triggers a full BPP or contraction stress testing.
Relationship to Doppler and growth surveillance
The BPP is one piece of a surveillance package. In FGR, umbilical artery Doppler is the best-validated tool for distinguishing the constitutionally small fetus from the growth-restricted fetus with true placental insufficiency, and integrating it into management reduces perinatal mortality. Serial biometry (biparietal diameter, head circumference, abdominal circumference, femur length) is repeated no more often than every 3 to 4 weeks, because expected interval growth is small relative to measurement error. A typical high-risk protocol therefore combines interval growth scans, umbilical artery (and, when indicated, middle cerebral artery) Doppler, fluid assessment, and NST or BPP. Importantly, a normal BPP does not erase the concern raised by severely abnormal Doppler findings such as reversed end-diastolic flow - those fetuses need daily or inpatient surveillance regardless of the biophysical score.
Worked example. At 36 weeks, a fetus of a mother with gestational hypertension shows 4 body movements, a hand that extends and re-flexes, one 45-second breathing episode, a deepest pocket of 2.8 cm, and a reactive NST: 10/10, reassuring. The same fetus one week later with a deepest pocket of 1.4 cm scores 8/10 with fluid 0 - and that isolated oligohydramnios, the chronic marker, is exactly the finding that may tip management toward delivery at term even though every acute parameter is intact.